Immunocore Holdings PLC expected to post a loss of 48 cents a share - Earnings Preview
06/08/2024 11:26
* Immunocore Holdings PLC IMCR.OQ IMCR.O is expected
to show a
rise in quarterly revenue when it reports results on August 8
for the period ending June 30 2024
* The Abingdon Oxfordshire-based company is expected to
report a
24.7% increase in revenue to $74.58 million from $59.79 million
a year ago, according to the mean estimate from 16 analysts,
based on LSEG data.
* LSEG's mean analyst estimate for Immunocore Holdings PLC
is for
a loss of 48 cents per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 17 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Immunocore
Holdings PLC is $87.00, above its last closing price
of $37.07.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM LSEG IBES ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT ESTIMATE MET, SE %
E® MISSED
Mar. 31 2024 -0.38 -0.36 -0.49 Missed -35.4
Dec. 31 2024 -0.28 -0.28 -0.40 Missed -47
Sep. 30 2023 -0.35 -0.35 0.05 Beat 113.8
Jun. 30 2023 -0.40 -0.41 -0.36 Beat 9.7
Mar. -0.45 -0.39 -0.43 Missed -10.7
31 2023
Dec. 31 2022 -0.01 0.00 -0.63 Missed -2,523
,264.5
Sep. 30 2022 -0.25 -0.32 0.14 Beat 141.7
Jun. 30 2022 -0.72 -0.82 -0.18 Beat 79.1
This summary was machine generated August 6 at 10:26 GMT. All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)